Saiba Animal Health AG signs a deal to test and develop another product candidate from its pipeline

Päffikon (SZ) Switzerland 16th of July 2021 – Saiba Animal Health AG reported today that it has entered into its fifth agreement with a leading Animal Health Company

Saiba Animal Health AG announced today the commencement of another collaboration with a major animal health company. The execution of this new agreement brings to five the number of pipeline projects Saiba AH has now out-licensed to top-tier animal health companies since 2014.

Dr Gary T. Jennings, CEO of Saiba Animal Health AG commented, “Saiba Animal Health is excited by the opportunity to team up with a leading animal health to advance another of our promising pipeline projects. The out-licensing of our fifth product candidate demonstrates the significant traction we have achieved with our platform technology. Industry leaders have developed an appreciation of the potential of our therapeutic virus-like particle vaccines to provide effective therapies for chronic disease and meaningful solutions to unmet needs in veterinary medicine”.

For further information, please contact

Saiba Animal Health AG
CH-8808 Pfäffikon (SZ),
Gary Jennings, PhD